Timosaponin composition and application thereof in viral myocarditis treatment

The invention discloses a timosaponin composition comprising timosaponin AIII, timosaponin BII and timosaponin N. The weight percentage of the timosaponin AIII is 22% to 34%; the weight percentage ofthe timosaponin BII is 18 to 30%; and the weight percentage of the timosaponin N is 10 to 17%. Accord...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: XU YINGJIA, XUE JINGUI, HUANG RITAI
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention discloses a timosaponin composition comprising timosaponin AIII, timosaponin BII and timosaponin N. The weight percentage of the timosaponin AIII is 22% to 34%; the weight percentage ofthe timosaponin BII is 18 to 30%; and the weight percentage of the timosaponin N is 10 to 17%. According to the invention, the proliferation of myocardial tissue viruses can be inhibited obviously; the myocardial cells and tissues can be protected well; and the treatment efficiency of viral myocarditis is improved. 本发明公开了一种知母皂苷组合物,所述组合物含有知母皂苷AⅢ、知母皂苷BⅡ和知母皂苷N,其中知母皂苷AⅢ的重量百分含量为22%~34%,知母皂苷BⅡ的重量百分含量为18%~30%,知母皂苷N的重量百分含量为10%~17%,本发明组合物能够明显抑制心肌组织病毒增值,发挥对心肌细胞及组织的保护作用,提高病毒性心肌炎的治疗有效率。